Literature DB >> 31140109

Nicotinic Acetylcholine Receptor Density in the "Higher-Order" Thalamus Projecting to the Prefrontal Cortex in Humans: a PET Study.

Valentina Garibotto1,2, Michael Wissmeyer3, Zoi Giavri4, Osman Ratib3, Fabienne Picard5,6.   

Abstract

PURPOSE: The parcellation of the thalamus into different nuclei involved in different corticothalamocortical loops reflects its functional diversity. The connections between the mediodorsal nucleus and the prefrontal cortex play a major role in cognition, particularly in the rapid processing of behaviorally relevant information. The thalamus is the brain region with the highest density in α4β2 nicotinic acetylcholine receptors, the main human nicotinic acetylcholine receptor subtype. The aim of this study was to investigate the possible role of the nicotinic cholinergic system in the thalamo-cortical loops measuring receptor density in different subregions of the thalamus, based on their cortical connectivity. PROCEDURES: We studied α4β2 nicotinic acetylcholine receptors using positron emission tomography and [18F]Fluoro-A-85380, a radiotracer specific for this receptor subtype, in 36 non-smoking male subjects, including 12 healthy controls and 24 patients with epilepsy. [18F]Fluoro-A-85380 ratio index of binding potential was compared by a repeated measures general linear model, including the thalamic subregions and the brain hemisphere as within-subject factor and clinical groups as between-subject factor.
RESULTS: The "prefrontal" thalamus, the subregion including the mediodorsal nucleus, had a significantly higher nicotinic acetylcholine receptor density than all other thalamic subregions. These findings were confirmed when analyzing solely the 12 healthy controls.
CONCLUSIONS: This particular neurochemical organization of the thalamus supports a major role of the cholinergic system in the loops between the thalamus and the prefrontal cortex. The highest nicotinic acetylcholine receptor density in the « higher-order thalamus » could partly explain the beneficial effect of acute nicotine on attentional and executive functions and possibly the pathophysiology of some neuropsychiatric disorders.

Entities:  

Keywords:  Fluoro-A-85380; Mediodorsal nucleus; Nicotinic acetylcholine receptor; PET; Thalamus

Mesh:

Substances:

Year:  2020        PMID: 31140109     DOI: 10.1007/s11307-019-01377-8

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  50 in total

Review 1.  Nicotine use in schizophrenia: the self medication hypotheses.

Authors:  Veena Kumari; Peggy Postma
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

2.  Shaker-related potassium channels in the central medial nucleus of the thalamus are important molecular targets for arousal suppression by volatile general anesthetics.

Authors:  Maria I Lioudyno; Alexandra M Birch; Brian S Tanaka; Yuri Sokolov; Alan L Goldin; K George Chandy; James E Hall; Michael T Alkire
Journal:  J Neurosci       Date:  2013-10-09       Impact factor: 6.167

3.  Smoking normalizes cerebral blood flow and oxygen consumption after 12-hour abstention.

Authors:  Manouchehr S Vafaee; Albert Gjedde; Nasrin Imamirad; Kim Vang; Mallar M Chakravarty; Jason P Lerch; Paul Cumming
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

4.  A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.

Authors:  J P Sullivan; D Donnelly-Roberts; C A Briggs; D J Anderson; M Gopalakrishnan; M Piattoni-Kaplan; J E Campbell; D G McKenna; E Molinari; A M Hettinger; D S Garvey; J T Wasicak; M W Holladay; M Williams; S P Arneric
Journal:  Neuropharmacology       Date:  1996-06       Impact factor: 5.250

5.  Nicotinic receptor abnormalities as a biomarker in idiopathic generalized epilepsy.

Authors:  Valentina Garibotto; Michael Wissmeyer; Zoi Giavri; Rachel Goldstein; Yann Seimbille; Margitta Seeck; Osman Ratib; Sven Haller; Fabienne Picard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

6.  Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys.

Authors:  M Giguere; P S Goldman-Rakic
Journal:  J Comp Neurol       Date:  1988-11-08       Impact factor: 3.215

7.  Topography of connections between human prefrontal cortex and mediodorsal thalamus studied with diffusion tractography.

Authors:  Johannes C Klein; Matthew F S Rushworth; Timothy E J Behrens; Clare E Mackay; Alex J de Crespigny; Helen D'Arceuil; Heidi Johansen-Berg
Journal:  Neuroimage       Date:  2010-03-04       Impact factor: 6.556

Review 8.  Acetylcholine receptors in dementia and mild cognitive impairment.

Authors:  Osama Sabri; Kai Kendziorra; Henrike Wolf; Hermann-Josef Gertz; Peter Brust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

9.  Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.

Authors:  Hiroyuki Okada; Yasuomi Ouchi; Mikako Ogawa; Masami Futatsubashi; Yuriko Saito; Etsuji Yoshikawa; Tatsuhiro Terada; Yumi Oboshi; Hideo Tsukada; Takatoshi Ueki; Mitsuo Watanabe; Takaji Yamashita; Yasuhiro Magata
Journal:  Brain       Date:  2013-08-24       Impact factor: 13.501

10.  Evaluation of partial volume effect correction methods for brain positron emission tomography: Quantification and reproducibility.

Authors:  Merisaari Harri; Teras Mika; Hirvonen Jussi; Olli S Nevalainen; Hietala Jarmo
Journal:  J Med Phys       Date:  2007-07
View more
  2 in total

Review 1.  New Cognitive Neurotechnology Facilitates Studies of Cortical-Subcortical Interactions.

Authors:  Byoung-Kyong Min; Matti S Hämäläinen; Dimitrios Pantazis
Journal:  Trends Biotechnol       Date:  2020-04-08       Impact factor: 19.536

2.  Thalamocortical Mechanisms for Nostalgia-Induced Analgesia.

Authors:  Ming Zhang; Ziyan Yang; Jiahui Zhong; Yuqi Zhang; Xiaomin Lin; Huajian Cai; Yazhuo Kong
Journal:  J Neurosci       Date:  2022-03-01       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.